Evidence map›Paper›PMID 40660738›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Educational attainment, electroencephalographic rhythms, cortical structure, and cognitive performance over 2 years in older adults with subjective memory complaints and brain amyloidosis.

Susanna Lopez, Harald Hampel, Claudio Del Percio, Giuseppe Noce, Roberta Lizio, Stefan J Teipel, Martin Dyrba, Gabriel González-Escamilla, Hovagim Bakardjian, Patrizia Andrea Chiesa and 15 more

Erratum issuedAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Susanna LopezDepartment of Physiology and Pharmacology "Erspamer", Sapienza University of Rome, Rome, Italy.
Harald HampelAlzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.
Claudio Del PercioDepartment of Physiology and Pharmacology "Erspamer", Sapienza University of Rome, Rome, Italy.
Giuseppe NoceIRCCS Synlab SDN, Naples, Italy.
Roberta LizioDepartment of Physiology and Pharmacology "Erspamer", Sapienza University of Rome, Rome, Italy.
Stefan J TeipelDepartment of Psychosomatic Medicine, University of Rostock, Rostock, Germany.
Martin DyrbaDepartment of Psychosomatic Medicine, University of Rostock, Rostock, Germany.
Gabriel González-EscamillaDepartment of Neurology, Saarland University, Homburg, Germany.
Hovagim BakardjianDepartment of Neurology, Institute of Memory and Alzheimer's Disease (IM2A), Pitié-Salpêtrière Hospital, Paris, France.
Patrizia Andrea ChiesaAlzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.
Enrica CavedoAlzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.
Andrea VergalloAlzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.
Pablo LemercierAlzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.
Giuseppe SpinelliCentre pour l'Acquisition et le Traitement des Images, (CATI platform), Pitié-Salpêtrière Hospital, Boulevard del'hôpital, Paris, France.
Michel J GrotheGerman Center for Neurodegenerative Diseases (DZNE)-Gehlsheimer Str., Rostock, Germany.
Marie-Claude PotierInstitut du Cerveau et de la Moelle épinière, ICM, INSERM U1127, CNRS UMR 7225, Sorbonne Université, Paris, France.
Fabrizio StocchiIRCCS San Raffaele, Rome, Italy.
Chiara ColettiIRCCS San Raffaele, Rome, Italy.
Raffaele FerriOasi Research Institute-IRCCS, Troina, Italy.
Matteo PardiniDipartimento di Neuroscienze, Oftalmologia, Genetica, Riabilitazione e Scienze Materno-infantili (DiNOGMI), Università di Genova, Genova, Italy.
Marie-Odile HabertDepartment of Neurology, Institute of Memory and Alzheimer's Disease (IM2A), Pitié-Salpêtrière Hospital, Paris, France.
Simone MarzialiHospital San Raffaele Cassino, Cassino, Italy.
Bruno DuboisDepartment of Neurology, Institute of Memory and Alzheimer's Disease (IM2A), Pitié-Salpêtrière Hospital, Paris, France.
Claudio BabiloniDepartment of Physiology and Pharmacology "Erspamer", Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-5245-9839
and INSIGHT‐preAD study group

Funding

AXA Research FundEuropean Commission GAP-101058516Foundation Plan-Alzheimer PHOENIXInvestissement d'Avenir ANR-10-AIHU-06Italian Ministry of Health PNRR-MAD-2022-12376415Italian Ministry of Health PNRR-MCNT2-2023-12377357Italian Ministry of University and Research MNESYS-CUP-D33C22001340002Italian Ministry of University and Research PON"Green-digital"Italian Ministry of University and Research "RomeTechnopole"-GA-ECS00000024
6 · The paper itself

Abstract

introductionWe investigated whether older adults with subjective memory complaints (SMC) and amyloid-β accumulation may show clinical progression over 2 years, as measured by resting-state electroencephalographic (rsEEG), structural magnetic resonance imaging (sMRI), and cognitive variables, depending on educational attainment.

methodsWe analyzed these markers in 84 SMC participants from INSIGHT-Pre-AD study, grouped by amyloid-β deposition (

resultsIn amyloid-negative individuals, higher educational attainment was linked to greater posterior rsEEG alpha activity, possibly reflecting neuroprotective effects. Conversely, amyloid-positive individuals with higher educational attainment showed reduced posterior rsEEG alpha rhythms and lower parietal cortical thickness, potentially indicating compensatory mechanisms counteracting early amyloidosis and neurodegeneration. No longitudinal changes were found in either group over 2 years. DISCUSSION: Education had a stable influence on rsEEG, sMRI, and cognitive markers over 2 years in SMC individuals. Longer follow-up periods should be used to monitor brain status with those markers. HIGHLIGHTS: Education, subjective memory complaint (SMC), and brain amyloid-β deposition. Stable influence of education on resting-state electroencephalographic (rsEEG), structural magnetic resonance imaging (sMRI), and cognitive markers over 2 years. Compensatory mechanism of education against early amyloidosis and neurodegeneration. Longer follow-up periods to monitor brain status in SMC older adults with those markers.

Indexed as

AmyloidosisBrainCerebral CortexCognitionEducational StatusMemory DisordersAgedAged, 80 and overAmyloid beta-PeptidesElectroencephalographyFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleNeuropsychological TestsAmyloid beta-Peptideseducational attainmentinsight‐pre‐AD studypreclinical Alzheimer's disease (AD) amyloid‐bresting‐state electroencephalographic (rsEEG) alpha rhythmsstructural magnetic resonance imaging (sMRI)subjective memory complaint (SMC)

Identifiers

PMID40660738
PMCPMC12260118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.